Patten & Patten Inc. TN Sells 270 Shares of iShares U.S. Pharmaceuticals ETF $IHE

Patten & Patten Inc. TN decreased its holdings in shares of iShares U.S. Pharmaceuticals ETF (NYSEARCA:IHE) by 1.0% in the 2nd quarter, according to its most recent 13F filing with the SEC. The fund owned 26,383 shares of the company’s stock after selling 270 shares during the period. Patten & Patten Inc. TN owned approximately 0.32% of iShares U.S. Pharmaceuticals ETF worth $1,729,000 at the end of the most recent reporting period.

Several other institutional investors and hedge funds also recently made changes to their positions in the business. LPL Financial LLC raised its position in shares of iShares U.S. Pharmaceuticals ETF by 47.6% during the 1st quarter. LPL Financial LLC now owns 119,866 shares of the company’s stock valued at $8,458,000 after acquiring an additional 38,678 shares during the last quarter. Goldman Sachs Group Inc. raised its position in shares of iShares U.S. Pharmaceuticals ETF by 4.8% during the 1st quarter. Goldman Sachs Group Inc. now owns 104,815 shares of the company’s stock valued at $7,396,000 after acquiring an additional 4,815 shares during the last quarter. Royal Bank of Canada raised its position in shares of iShares U.S. Pharmaceuticals ETF by 0.3% during the 1st quarter. Royal Bank of Canada now owns 101,984 shares of the company’s stock valued at $7,197,000 after acquiring an additional 325 shares during the last quarter. Grimes & Company Inc. bought a new stake in shares of iShares U.S. Pharmaceuticals ETF during the 2nd quarter valued at $1,468,000. Finally, Massachusetts Wealth Management raised its position in shares of iShares U.S. Pharmaceuticals ETF by 2.1% during the 2nd quarter. Massachusetts Wealth Management now owns 15,720 shares of the company’s stock valued at $1,030,000 after acquiring an additional 325 shares during the last quarter.

iShares U.S. Pharmaceuticals ETF Stock Performance

Shares of iShares U.S. Pharmaceuticals ETF stock opened at $74.18 on Friday. The firm has a fifty day moving average of $71.32 and a two-hundred day moving average of $67.62. The stock has a market capitalization of $597.15 million, a price-to-earnings ratio of 17.75 and a beta of 0.70. iShares U.S. Pharmaceuticals ETF has a 52 week low of $58.97 and a 52 week high of $76.14.

iShares U.S. Pharmaceuticals ETF Company Profile

iShares U.S. Pharmaceuticals ETF, formerly iShares Dow Jones U.S. Pharmaceuticals Index Fund (the Fund), is an exchange traded fund. The Fund seeks investment results that correspond generally to the price and yield performance of the Dow Jones U.S. Select Pharmaceuticals Index (the Index). The Index measures the performance of the pharmaceuticals sector of the United States equity market, and includes pharmaceutical companies such as manufacturers of prescription or over-the-counter drugs or vaccines, but excludes producers of vitamins.